BLID is a drug-responsive target of FOXO3a and multi-omics analysis reveals survival mechanisms and therapeutic vulnerabilities in BLID-deficient breast cancer cellsSivaramakrishna Yadavalli, Usha N. Kasid|Oncology Letters|2025Cited by 0